| Orders | Qty | Bid |
|---|---|---|
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| Ask | Qty | Orders |
|---|---|---|
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
Zota Health Care Limited is an Indian pharmaceutical company established in 2000, engaged in drug development, manufacturing, and marketing across pharmaceuticals, nutraceuticals, ayurvedic formulations, and over-the-counter (OTC) products for domestic and international markets. Headquartered in Surat, the company operates through a hybrid model combining its own manufacturing capabilities with a vast retail and distribution footprint. Its flagship retail brand, Davaindia, is a private-sector generic pharmacy chain focusing on affordable alternatives to branded medicines, with a nationwide network of 1,582 operational stores as of March 31, 2025.
Zota serves customers in 26 Indian states and 30 countries globally, operating one plant and five offices in India plus an international office. Its portfolio includes over 4,000 products, supplying more than 1,050 distributors across India. Davaindia offers 2,000+ SKUs and reaches over 2.44 crore consumers. As of March 31, 2025, Zota Health Care had five subsidiaries.
Manufactures and markets pharmaceuticals, nutraceuticals, ayurvedic formulations, and OTC products, operating a large retail pharmacy chain and a broad distribution network.
Revenue in FY 2024-25 was predominantly from the Davaindia retail pharmacy segment (64%) and Everyday Herbal Group (4%), with domestic sales accounting for 22% and exports contributing 11%. The company’s presence spans 26 states in India and 30 countries abroad.

Develops, manufactures, and markets pharmaceutical, nutraceutical, ayurvedic, and OTC products in domestic and international markets; operates Davaindia pharmacy chain focused on affordable generics.
Operates across 26 Indian states and 30 countries, with 1,582 Davaindia stores in 23 states and 2 union territories as of March 31, 2025.
Davaindia retail (64%), domestic sales (22%), exports (11%), and Everyday Herbal Group (4%).